Tianyao Holdings: revenue of amino acid segment for H1 2022 falls

On 27 Aug., Tianjin Tianyao Pharmaceuticals Co., Ltd. (Tianyao Holdings) released the semi-annual report for H1 2022. The performance of the company's amino acid segment for H1 2022Operating revenue: USD30.30 million (RMB208.56 million), down 8.41% Y...

Amino Acids China E-News 202209

www.cnchemicals.com